hsa-miR-410-3p appears to directly target STAT3, leading to a reduction of IL-10 in T cells of patients with systemic lupus erythematosus (94), and was also shown to be elevated in the plasma of these patients (95). The gene discussed is IL10; the disease is systemic lupus erythematosus.